TONI BOWYER: Open Payments
NPI 1003847286 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 65 payments from 16 companies in 2025. Trend: 2023 $606 · 2024 $987 · 2025 $1,388
Food & beverage: $1,354Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $383 |
| GENZYME CORPORATION | 25 | $342 |
| Novartis Pharmaceuticals Corporation | 8 | $205 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Organon LLC | 3 | $52 |
| PFIZER INC. | 2 | $45 |
| Amgen Inc. | 1 | $34 |
| BioCryst US Sales Co., LLC | 1 | $34 |
| Paratek Pharmaceuticals, Inc. | 1 | $30 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, Rhapsido, Xhance, CIBINQO, TEZSPIRE, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
